Table 3.

Multivariate analysis of functional outcomes and mortality

Outcome	Overall (n = 74)	Hp1-1 (n = 11)	Hp2-1 (n = 39)	Hp2-2 (n = 24)	Hp1-1/2-1 (n = 50)	95% CI*	P value*
GOSE at discharge, mean ± SD	3.1 ± 1.5	3.3 ± 1.3	3.4 ± 1.5	2.7 ± 1.5	3.4 ± 1.5	−1.60–0.121	0.091
GOSE at 6 wk, mean ± SD	3.9 ± 2.0	4.5 ± 1.9	3.9 ± 1.8	3.6 ± 2.2	4.1 ± 1.8	−1.86–0.507	0.256
GOSE at 12 mo, mean ± SD	5.2 ± 2.5	5.4 ± 2.7	5.5 ± 2.3	4.6 ± 2.8	5.5 ± 2.3	−2.92–0.030	0.055
mRS at discharge, mean ± SD	3.9 ± 1.3	4.1 ± 1.2	3.7 ± 1.3	4.0 ± 1.4	3.8 ± 1.3	−0.141–1.25	0.114
mRS at 6 wk, mean ± SD	3.1 ± 1.7	3.4 ± 1.8	2.8 ± 1.6	3.5 ± 1.8	2.9 ± 1.7	−0.090–1.78	0.076
mRS at 12 mo, mean ± SD	2.5 ± 2.0	2.5 ± 2.3	2.2 ± 1.7	2.9 ± 2.3	2.2 ± 1.9	−0.006–2.38	0.051
Mortality, n (%)	11 (14.9)	1 (9.1)	4 (10.3)	6 (25.0)	5 (10.0)	0.871–13.3†	0.079†

^*For comparison between Hp2-2 and Hp1-1/2-1 controlling for age, GCS, WFNS, Fisher grade, Hunt–Hess grade, aneurysm size, and treatment type.

^†OR = 3.3, for comparison between Hp2-2 and Hp1-1/2-1 controlling for age.